|7th March 2016
In our previous article, we talked about how to mature your organisation’s approach to content strategy. We covered off three key things you can do to move your company forward in 2016. However, not all organisations are in a position to look at maturity – for some, there’s still a pressing question that needs answering: Why does content need a strategy?
In this article, Content Marketing Manager Liz Inskip and guest blogger Adwoa Baah explain how having a documented strategy for content creation, distribution, management, and governance will empower your brand teams and create organisational efficiencies.
A documented strategy for content creation ensures that all content serves a strategic purpose, and is in line with business objectives, as well as customer needs. When content is brought into the strategic process at the beginning, it can shape thinking and drive the overall brand strategy.
For example, some of our clients have the problem of having too much content and no content owners. There isn’t a documented strategy in place for content creation, so new content is constantly being created to meet brand teams’ needs. This tends to mean that there is a proliferation of content, but no strategic guidance around how that content should be created or understanding of how each piece of content will meet business objectives and customer needs. In these cases, a documented strategy has empowered the brand teams to create less content, but the content that was created was purposeful and served a strategic purpose.
|14th February 2019
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence.
|6th February 2019
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry.
|1st February 2019
MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget.